Biomarker development targeting unmet clinical needs.
| dc.contributor.author | Monaghan, Phillip J | |
| dc.contributor.author | Lord, S | |
| dc.contributor.author | St John, A | |
| dc.contributor.author | Sandberg, S | |
| dc.contributor.author | Cobbaert, C | |
| dc.contributor.author | Lennartz, L | |
| dc.contributor.author | Verhagen-Kamerbeek, W | |
| dc.contributor.author | Ebert, C | |
| dc.contributor.author | Bossuyt, P | |
| dc.contributor.author | Horvath, A | |
| dc.date.accessioned | 2016-09-06T09:42:38Z | |
| dc.date.available | 2016-09-06T09:42:38Z | |
| dc.date.issued | 2016-09-01 | |
| dc.identifier.citation | Biomarker development targeting unmet clinical needs. 2016, 460:211-9 Clin. Chim. Acta | en |
| dc.identifier.issn | 1873-3492 | |
| dc.identifier.pmid | 27374304 | |
| dc.identifier.doi | 10.1016/j.cca.2016.06.037 | |
| dc.identifier.uri | http://hdl.handle.net/10541/619899 | |
| dc.description.abstract | The introduction of new biomarkers can lead to inappropriate utilization of tests if they do not fill in existing gaps in clinical care. We aimed to define a strategy and checklist for identifying unmet needs for biomarkers. | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to Clinica chimica acta; international journal of clinical chemistry | en |
| dc.title | Biomarker development targeting unmet clinical needs. | en |
| dc.type | Article | en |
| dc.contributor.department | Department of Clinical Biochemistry, The Christie Pathology Partnership | en |
| dc.identifier.journal | Clinica Chimica Acta | en |
| html.description.abstract | The introduction of new biomarkers can lead to inappropriate utilization of tests if they do not fill in existing gaps in clinical care. We aimed to define a strategy and checklist for identifying unmet needs for biomarkers. |